期刊文献+

阻塞性睡眠呼吸暂停综合征患者血清25-羟维生素D浓度与左心室肥厚的关系 被引量:8

Serum 25-Hydroxy Vitamin D Concentration is Positively Related to Left Ventricular Hypertrophy in Obstructive Sleep Apnea-hypopnea Syndrome Patients
暂未订购
导出
摘要 目的探讨在阻塞性睡眠呼吸暂停综合征患者中25-羟维生素D浓度与心脏结构异常的关系。方法选择2010年8月至2012年4月住院的337例阻塞性睡眠呼吸暂停综合征患者,采用酶联免疫法测定血清25-羟维生素D浓度,超声心动图测量并计算左心室质量指数,定义左心室质量指数≥125 g/m2(男)、≥120 g/m2(女)为左心室肥厚。结果 (1)与轻至中度阻塞性呼吸睡眠暂停综合征(5次/小时≤睡眠呼吸暂停低通气指数<30次/小时,n=111)组相比,重度阻塞性睡眠呼吸暂停综合征组(n=226)的左心室质量指数、左心室肥厚的发生率、体质指数显著增加(P<0.01),血清25-羟维生素D浓度明显降低。(2)多元回归分析显示四分位数25-羟维生素D浓度与左心室肥厚发生具有独立相关性(校正OR=4.11,95%CI:1.15~12.70,P<0.01),在校正肥胖及其他危险因素后,仍有相关性。另外,血清25-羟维生素D浓度与体质指数呈负相关。结论血清25-羟维生素D浓度降低提示重度阻塞性睡眠呼吸暂停综合征患者发生左心室肥厚的可能性增加。 Aim To investigate whether increased plasma levels of serum 25-hydroxy vitamin D [ 25 (OH) VD ] are associated with cardiac structural and functional abnormalities in obstructive sleep apnea-hypopnea syndrome (OSAHS) pa- tients. Methods We documented 337 consecutive patients with OSAHS. Left ventricular hypertrophy (LVH) [ left ventricular mass index (LVMI)≥25 g/m^2 in male, and LVMI ≥ 120 g/m^2 in female ] was determined by echocardiography. The serum 25-hydroxy vitamin D concentration was measured by using enzyme-linked immunosorbent assay (ELISA) method. Results The LVMI, prevalence rate of LVH and body mass index (BMI) were higher in the subjects with severe OSAHS (apnoea-hypopnoea index≥30/h, LVH 75%, n = 226) than in those with mild to moderate OSAHS (LVH 40%, n = 111 ) (P 〈 0. 01 ), and serum 25 (OH) VD levels were lower in the severe OSAHS groups. Although the serum 25 (OH) VD level showed a negative correlation with BMI, the results of binary logistic regression analysis demonstrated that the quar- tile value of 25 (OH)VD was an independent significant variable for the identification of LVH (adjusted OR in quartile = 4. 11, 95% CI : 1. 15-12. 70, P 〈 0. 01 ), even after adjusting for obesity and other risk factors. Conclusion Decreased serum levels of 25(OH) VD do seem to reflect an increased likelihood of LVH in patients with severe OSAHS.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2013年第2期169-172,181,共5页 Chinese Journal of Arteriosclerosis
关键词 阻塞性睡眠呼吸暂停综合征 25-羟维生素D 左心室肥厚 Obstructive Sleep Apnea-hypopnea Syndromes 25-Hydroxy Vitamin D Left Ventricular Hypertrophy
  • 相关文献

参考文献19

  • 1朱学创,李利华,尹雪艳.维生素D和高血压发病的研究进展[J].中国动脉硬化杂志,2010,18(12):1001-1003. 被引量:28
  • 2Holick MF. Vitamin D deficiency[J].New England Journal of Medicine,2007,(03):266-281.
  • 3Levin A,Djurdjev O,Thompson C. Canadian randomized trial of hemoglobin aintenance to prevent or delay left ventricular mass growth in patients with CKD[J].American Journal of Kidney Diseases,2005,(05):799-811.
  • 4Autier P,Gandini S. Vitamin D supplementation and total mortality:a meta-analysis of randomized controlled trials[J].Archives of Internal Medicine,2007,(16):1730-1737.doi:10.1001/archinte.167.16.1730.
  • 5Wang TJ,Pencina M J,Booth SL. Vitamin D deficiency and risk of cardiovascular disease[J].Circulation,2008,(04):503-511.
  • 6周春蕾,陆凤翔,苗登顺.1,25二羟维生素D3的心血管系统保护作用研究进展[J].中国动脉硬化杂志,2007,15(3):236-238. 被引量:12
  • 7Arias MA,Garcia-Rio F,Alonso-Fernandez A. Obstructive sleep apnea syndrome affects left ventricular diastolic function:effects of nasal continuous positive airway pressure in men[J].Circulation,2005,(03):375-383.doi:10.1161/CIRCULATIONAHA.104.501841.
  • 8Alam I,Lewis K,Stephens JW. Obesity,metabolic syndrome and sleep apnoea:all pro-inflammatory states[J].Obesity Reviews,2007,(02):119-127.
  • 9Tsara V,Amfiloehiou A,Papagrigorakis MJ. Guidelines for diagnosis and treatment of sleep-related breathing disorders in adults and children[J].Hippokratia,2009,(04):187-191.
  • 10Morgenthaler TI,Lee-Chiong T,Alessi C. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders:an american academy of sleep medicine report[J].Journal SLEEP,2007,(11):1445-1459.

二级参考文献63

  • 1周春蕾,陆凤翔,苗登顺.1,25二羟维生素D3的心血管系统保护作用研究进展[J].中国动脉硬化杂志,2007,15(3):236-238. 被引量:12
  • 2黄锟,陶芳标.儿童维生素D缺乏与1型糖尿病[J].国外医学(卫生学分册),2005,32(2):83-87. 被引量:5
  • 3[1]Holick MF.VitaminD:a millennium perspective[J].J Cell Biochem,2003,88 (2):296-307.
  • 4[2]Zittermann A.Vitamin D in preventive medicine:are we ignoring the evidence[J]? Br J Nutr,2003,89 (5):552-572.
  • 5[3]Hanssler MR,Whitfield GK,Haussler CA,Hsieh JC,Thompson PD,Selznick SH,et al.The nuclear vitamin D receptor:biological and molecular regulatory properties revealed[J].J Bone Miner Res,1998,13 (3):325-349.
  • 6[4]Li YC,pirro AE,Amling M,Delling G,Baron R,Bronson R,et al.Targeted ablation of the vitamin D receptor:an aminal modeol of vitamin D-dependent rickets type Ⅱ with alopecia[J].Proc Nati Acad Sci USA,1997,94 (18):9 831-835.
  • 7[5]Simpson RU,Weishaar RE.Involvement of 1,25-dihydroxyvitamin D3 in regulating myocardial calcium metabolism:physiological and pathological actions[J].Cell calcium,1988,9 (5-6):285-292.
  • 8[6]Holick MF.Vitamin D:important of prevention of osteoporosis,cardiovascular heart disease,type I diabetes,autoimmune diseases,and some cancers[J].South Med J,2005,98 (10):1 024-027.
  • 9[7]Holick MF.Vitamin D:importance in the prevention of cancers,type I diabetes,heart disease,and osteoporosis[J].Am J Clin Nutr,2004,79 (3):362-371.
  • 10[9]Teng M,Wolf M,Ofsthun MN,Lazarus JM,Hernan MA,Camarqo CA Jr,et al.Activated injectable vitamin D and hemodialysis survival:a historical cohort study[J].J Am Soc Nephrol,2005,16 (4):1 115-125.

共引文献37

同被引文献78

引证文献8

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部